SG Americas Securities’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,227
Closed -$181K 3629
2025
Q1
$181K Buy
3,227
+675
+26% +$40.4K ﹤0.01% 2605
2024
Q4
$157K Buy
+2,552
New +$165K ﹤0.01% 2375
2023
Q2
Sell
-1,402
Closed -$133K 3203
2023
Q1
$133K Buy
+1,402
New +$129K ﹤0.01% 2726
2021
Q4
Sell
-2,039
Closed -$189K 3828
2021
Q3
$189K Buy
+2,039
New +$180K ﹤0.01% 3271
2020
Q3
Sell
-2,042
Closed -$181K 3478
2020
Q2
$181K Buy
2,042
+686
+51% +$61.6K ﹤0.01% 2942
2020
Q1
$128K Buy
+1,356
New +$126K ﹤0.01% 2815
2018
Q1
Sell
-2,326
Closed -$189K 3561
2017
Q4
$189K Buy
+2,326
New +$182K ﹤0.01% 2474
2017
Q2
Sell
-1,617
Closed -$101K 3533
2017
Q1
$101K Buy
+1,617
New +$102K ﹤0.01% 2987
2016
Q4
Sell
-1,771
Closed -$106K 3475
2016
Q3
$106K Buy
+1,771
New +$113K ﹤0.01% 3033
2014
Q4
Sell
-2,851
Closed -$139K 3376
2014
Q3
$139K Buy
+2,851
New +$145K ﹤0.01% 2198

Other funds holding UTMD

SG Americas Securities's UTMD Position: Q2 2025 in Review

SG Americas Securities sold out of Utah Medical Products (UTMD) in Q2 2025, closing a stake of 3,227 shares — an estimated $181K sold.

SG Americas Securities first reported a position in UTMD in Q3 2014 and held it in 10 quarters. The position peaked at $189K in Q3 2021. 112 funds tracked by Wall St. Rank hold UTMD as of Q2 2025.

  • SG Americas Securities reported no remaining Utah Medical Products position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 3,227 Utah Medical Products shares in Q2 2025, an estimated $181K.
  • SG Americas Securities first reported a position in Utah Medical Products in Q3 2014 and held it in 10 quarters.
  • SG Americas Securities's Utah Medical Products position peaked at $189K in Q3 2021.
  • 112 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.